David Rescott
Stock Analyst at Baird
(3.56)
# 764
Out of 5,182 analysts
84
Total ratings
57.14%
Success rate
4.51%
Average return
Main Sectors:
Top Industries:
Stocks Rated by David Rescott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EW Edwards Lifesciences | Maintains: Neutral | $85 → $87 | $83.46 | +4.24% | 8 | Apr 24, 2026 | |
| BSX Boston Scientific | Maintains: Outperform | $86 → $78 | $59.95 | +30.11% | 11 | Apr 23, 2026 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $575 → $610 | $470.99 | +29.51% | 4 | Apr 22, 2026 | |
| PRCT PROCEPT BioRobotics | Initiates: Neutral | $30 | $24.09 | +24.53% | 1 | Mar 6, 2026 | |
| MDT Medtronic | Maintains: Neutral | $103 → $100 | $82.92 | +20.60% | 9 | Feb 18, 2026 | |
| PEN Penumbra | Downgrades: Neutral | $345 → $374 | $327.98 | +14.03% | 32 | Jan 16, 2026 | |
| SIBN SI-BONE | Maintains: Buy | $21 → $23 | $13.15 | +74.90% | 8 | Dec 18, 2025 | |
| HAE Haemonetics | Maintains: Outperform | $87 → $99 | $60.48 | +63.69% | 2 | Dec 15, 2025 | |
| LIVN LivaNova | Maintains: Outperform | $63 → $70 | $63.41 | +10.39% | 6 | Nov 13, 2025 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $111 → $110 | $67.43 | +63.13% | 3 | Apr 25, 2025 |
Edwards Lifesciences
Apr 24, 2026
Maintains: Neutral
Price Target: $85 → $87
Current: $83.46
Upside: +4.24%
Boston Scientific
Apr 23, 2026
Maintains: Outperform
Price Target: $86 → $78
Current: $59.95
Upside: +30.11%
Intuitive Surgical
Apr 22, 2026
Maintains: Outperform
Price Target: $575 → $610
Current: $470.99
Upside: +29.51%
PROCEPT BioRobotics
Mar 6, 2026
Initiates: Neutral
Price Target: $30
Current: $24.09
Upside: +24.53%
Medtronic
Feb 18, 2026
Maintains: Neutral
Price Target: $103 → $100
Current: $82.92
Upside: +20.60%
Penumbra
Jan 16, 2026
Downgrades: Neutral
Price Target: $345 → $374
Current: $327.98
Upside: +14.03%
SI-BONE
Dec 18, 2025
Maintains: Buy
Price Target: $21 → $23
Current: $13.15
Upside: +74.90%
Haemonetics
Dec 15, 2025
Maintains: Outperform
Price Target: $87 → $99
Current: $60.48
Upside: +63.69%
LivaNova
Nov 13, 2025
Maintains: Outperform
Price Target: $63 → $70
Current: $63.41
Upside: +10.39%
Merit Medical Systems
Apr 25, 2025
Maintains: Outperform
Price Target: $111 → $110
Current: $67.43
Upside: +63.13%